Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network

Frontiers in Pharmacology
Feifei GuoHongjun Yang

Abstract

Hypertensive nephropathy (HN) is a medical condition in which chronic high blood pressure causes different kidney damage, including vascular, glomerular and tubulointerstitial lesions. For HN patients, glomerular and tubulointerstitial lesions occur in different renal structure with distinct mechanisms in the progression of renal damage. As an extraction of Eucommia ulmoides, Quan-du-zhong capsule (QDZJN) has the potential to treat HN due to antihypertensive and renal protective activities. Complicated mechanism of HN underlying various renal lesions and the "multi-component and multi-target" characteristics of QDZJN make identifying drug positioning for various renal lesions of HN complex. Here, we proposed an approach based on drug perturbation of disease network robustness, that is used to assess QDZJN positioning for various HN lesions. Topological characteristics of drug-attacked nodes in disease network were used to evaluated nodes importance to network. To evaluate drug attack on the whole disease network of various HN lesions, the robustness of disease networks before/after drug attack were assessed and compared with null models generated from random networks. We found that potential targets of QDZJN were specifically e...Continue Reading

References

Jun 1, 1977·Acta Physiologica Scandinavica·B FolkowS E Ricksten
Jul 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K A Nath
May 3, 2003·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·L O SomovaF O Shode
Sep 29, 2004·Hypertension·Anil K Bidani, Karen A Griffin
Dec 23, 2004·American Journal of Physiology. Renal Physiology·Ming-Zhi ZhangRaymond C Harris
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael P KuligowskiMichael J Hickey
Feb 24, 2007·Nature Reviews. Drug Discovery·Hiroaki Kitano
Mar 16, 2007·Kidney International·C-M Hao, M D Breyer
Aug 19, 2007·Journal of Cardiovascular Pharmacology·Eyal Leibovitz, Ernesto L Schiffrin
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Sep 9, 2009·Journal of Medicinal Food·Bong Hyun KimIl-Moo Chang
Feb 4, 2010·JAMA : the Journal of the American Medical Association·Brenda R HemmelgarnUNKNOWN Alberta Kidney Disease Network
Mar 30, 2010·Journal of Ethnopharmacology·Li-fang LuoDong-sheng Ouyang
Sep 8, 2010·International Journal of Molecular Medicine·Yi ZhouLing Zheng
Dec 21, 2011·Journal of Medicinal Food·Erwei LiuTao Wang
Jun 23, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Celine C BerthierMatthias Kretzler
Nov 6, 2012·The New England Journal of Medicine·Hans-Henrik ParvingUNKNOWN ALTITUDE Investigators
Jun 26, 2013·Trends in Pharmacological Sciences·Jianxiong Jiang, Ray Dingledine
Jul 13, 2013·Chinese Journal of Natural Medicines·Pooja Bhardwaj, Deepa Khanna
Sep 10, 2014·Current Protocols in Bioinformatics·Gang SuGary D Bader
May 23, 2015·BioMed Research International·Domenico SantoroLuca De Nicola
Mar 11, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Li-Chun HoYau-Sheng Tsai
Apr 5, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Tarique HussainYulong Yin
Oct 4, 2016·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G ColussiL A Sechi
Dec 8, 2016·Nucleic Acids Research·Damian SzklarczykChristian von Mering
Mar 4, 2017·International Journal of Molecular Sciences·Maria Elisa Drago-SerranoMireya de la Garza
Dec 20, 2017·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Marie-Louise SyrenCarlo Agostoni

❮ Previous
Next ❯

Citations

Oct 1, 2019·Archives of Physiology and Biochemistry·Milad AshrafizadehSaeed Samarghandian
Oct 16, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Kun Xia HuXiao Song
Jun 20, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jian ChenYong-Bing Cao
Aug 1, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xin-Xin LingShan Gao

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE37455
GSE37460

Methods Mentioned

BETA
biopsies

Software Mentioned

BATMAN
TISSUE
Cytoscape
UP
DisGeNET
TCM
DAVID
STRING

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
G D'Amico
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
G A MüllerF Strutz
Yao xue xue bao = Acta pharmaceutica Sinica
Yan Xu, Xue-jun Li
© 2022 Meta ULC. All rights reserved